Добірка наукової літератури з теми "Antiviraux – Conception"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Зміст
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Antiviraux – Conception".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Antiviraux – Conception"
Couvreur, Patrick. "La « squalénisation » : un exemple de conception de nanomédicaments anticancéreux et antiviraux." Bulletin de l'Académie Nationale de Médecine 193, no. 3 (March 2009): 663–74. http://dx.doi.org/10.1016/s0001-4079(19)32558-0.
Повний текст джерелаHu, Zhao X., Yi N. Ye, Wei G. Wu, Xu J. Liang, Qi W. Wu, Ao Zhang, Xing R. Zheng, Zhi L. Gao, Liang Peng, and Chan Xie. "Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal Safety." Canadian Journal of Gastroenterology and Hepatology 2019 (April 1, 2019): 1–8. http://dx.doi.org/10.1155/2019/9703907.
Повний текст джерелаBragina, E. E. "Viral infection of spermatozoa. Part 1. Hepatitis B virus and human papillomavirus (review)." Andrology and Genital Surgery 21, no. 4 (February 12, 2021): 12–19. http://dx.doi.org/10.17650/2070-9781-2020-21-4-12-19.
Повний текст джерелаBragina, E. E. "Viral infection of sperm. Part 2. Human herpes viruses, human immunodeficiency virus, hepatitis C virus, Zika virus (review)." Andrology and Genital Surgery 21, no. 4 (February 12, 2021): 20–30. http://dx.doi.org/10.17650/2070-9781-2020-21-4-20-30.
Повний текст джерелаKovalyk, V. Р., V. V. Malinovskaya, A. N. Shuvalov, L. F. Kurilo, К. I. Yurlov, М. A. Gomberg, and A. A. Kushch. "Cytomegalovirus infection and male infertility: case report." Andrology and Genital Surgery 22, no. 1 (April 22, 2021): 85–89. http://dx.doi.org/10.17650/1726-9784-2021-22-1-85-89.
Повний текст джерелаDéléris, Gérard. "Use of Organosilicon Compounds towards the Rational Design of Antiparasitic and Antiviral Drugs." Metal-Based Drugs 2, no. 3 (January 1, 1995): 143–51. http://dx.doi.org/10.1155/mbd.1995.143.
Повний текст джерелаRana, Ramesh, Rajkumar Dangal, Yogendra Singh, Ram Bahadur Gurung, Bhim Rai, and Amit Kumar Sharma. "Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review." Journal of Nepal Medical Association 59, no. 241 (September 11, 2021): 942–53. http://dx.doi.org/10.31729/jnma.5501.
Повний текст джерелаAkbar, Sheikh Mohammad Fazle, Mamun Al Mahtab, Sakirul Khan, Osamu Yoshida, and Yoichi Hiasa. "Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection." Vaccines 10, no. 10 (September 30, 2022): 1644. http://dx.doi.org/10.3390/vaccines10101644.
Повний текст джерелаLopes Araújo, Daniel, José Eufrazino Júnior, Vinicius Santos Silva, Carla Franco Mendonça de Araújo, Thaynara Hevellin Evangelista, Hilary Hevellin Evangelista, Geovana Maciel Lima, et al. "AVALIAÇÃO DO POTENCIAL TRIPANOCIDA DE DERIVADOS TIOSSEMICARBAZONAS: UMA REVISÃO." RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2, no. 9 (October 11, 2021): e29658. http://dx.doi.org/10.47820/recima21.v2i9.658.
Повний текст джерелаKagramanova, Zh A., P. E. Lanshchakova, V. V. Malinovskaya, A. A. Svistunov, and E. N. Vizhlova. "Correlations in the pathogenesis by early pregnancy loss." Voprosy ginekologii, akušerstva i perinatologii 20, no. 4 (2021): 45–54. http://dx.doi.org/10.20953/1726-1678-2021-4-45-54.
Повний текст джерелаДисертації з теми "Antiviraux – Conception"
Note, Reine. "Conception, synthèse et évaluation d'inhibiteurs mixtes de la transcriptase inverse du VIH." Paris 5, 2000. http://www.theses.fr/2000PA05P606.
Повний текст джерелаBarral, Karine. "Conception, modélisation, synthèse et évaluation des propriétés antivirales de nouveaux analogues de nucléosides." Aix-Marseille 2, 2003. http://www.theses.fr/2003AIX22075.
Повний текст джерелаLefebvre, Isabelle. "Essai de rationalisation dans la conception de pronucléotides à visée anti-VIH." Montpellier 2, 1994. http://www.theses.fr/1994MON20252.
Повний текст джерелаGaleotti, Nathalie. "Conception et synthèse de mimes peptidiques analogues de substrats de la protéase du VIH." Montpellier 2, 1993. http://www.theses.fr/1993MON20002.
Повний текст джерелаMalnuit, Vincent. "Conception, synthèse et étude de nouveaux analogues de nucléosides : application dans le domaine des antiviraux et antitumoraux." Nice, 2011. http://www.theses.fr/2011NICE4001.
Повний текст джерелаDespite significant progress made in recent years, the fight against viral infections and cancer remains a global health problem. This brief summary underlines the need for new compounds in order to overcome the limits of the drugs currently available. Therefore, there is a significant need to develop new methodologies for the synthesis of new bioactive molecules, and new analytical tools for the study of the involved drug/biological target interactions. To this end, the main objective of this thesis is to address these issues following the investigation of three major themes. We first developed a strategy for the synthesis of 1,2,3-triazolyl-nucleosides substituted at positions 4 and 5, using a tandem click/electrophilic addition reaction. Biological tests showed strong anticancer activity against CML for these compounds. We then developed a strategy for post-synthetic modification of oligonucleotides by click chemistry. This reaction allows post-synthetic transformation of oligonucleotides bearing an azide group in a site-specific manner. Therefore, this strategy has a great potential in various applications such as specific labelling of nucleic acids. Finally, we designed a new family of HIV-1 TAR RNA ligands that selectively bind to secondary structures such as stem-loop or stem-bulge, through a cooperative action of several recognition patterns. Among them, we used a modified nucleobase that can specifically recognize an AU base pair. Meanwhile, a new method of screening for this type of base triplets by mass spectrometry is being investigated
Druillennec-Rodière, Sabine. "Démonstration d'une interaction directe entre la protéine de nucléocapside NCp7 et la transcriptase inverse de VIH-1 : caractérisation et inhibition. Conception de nucléo- et peptidomimétiques susceptibles d'inhiber les activités de la NCp7." Paris 5, 1999. http://www.theses.fr/1999PA05P606.
Повний текст джерелаToulouze, Bénédicte. "Sida : revue des obstacles à la mise au point d'un vaccin anti-VIH." Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P060.
Повний текст джерелаCallendret, Benoît. "Conception et évaluation de différentes approches vaccinales contre le coronavirus associé au syndrome respiratoire aigu sévère." Paris 7, 2006. http://www.theses.fr/2006PA077222.
Повний текст джерелаSevere acute respiratory syndrome associated coronavirus (SARS-CoV) emerged in late 2002 and caused an epidemic of atypic pneumonia in humans. Here, we describe three vaccine candidates designed to induce neutralizing antibodies against the viral S glycoprotein, which are the main effectors of the protective immune response. We demonstrated that efficient expression of S gene in mammalian cell lines required the use of optimized vectors containing an intron and post-transcriptional regulatory elements such as WPRE and CTE. Upon immunization of mice with low doses of naked DNA, only intron and WPRE-containing vectors were able to provide protection against challenge with SARS-CoV. We also established stable cell lines constitutively secreting a soluble form of the S protein (Ssol). The immunogenicity of purified Ssol was studied in mouse and hamster models. Two injections of the Ssol polypeptide adjuvanted with Alum induced a strong and long-lasting Th2 immune response comprising high levels of SARS-CoV-neutralizing antibodies. Upon intranasal challenge with SARS-CoV, virus replication was strongly reduced in the lungs of immunized animals and hamsters were protected from the occurrence of lesions in the respiratory tract. Moreover, the use of two new adjuvants developed by GlaxoSmithKline Biologicals further increased the anti-S humoral response and the Thl component of the immune response. Concurrently, we developed HIV-based lentiviral vectors expressing the full-length S protein as an alternate SARS vaccine candidate. In the hamster model, a single injection of these vectors induced a neutralizing antibody response similar to that induced by two injections of Ssol
Abuduaini, Tuniyazi. "Génération de nouveaux acyclonucléosides phosphonates oléfiniques et 1-C-arylglycosides." Electronic Thesis or Diss., Orléans, 2021. http://www.theses.fr/2021ORLE3200.
Повний текст джерелаNucleosides and their analogues constitute the main family of antivirals and anticancer drugs. They provide an extremely powerful tool in effectively combating viral infections associated with many viruses such as HIV, HBV, HCV, CMV, VZV and HSV; they have been at the center of antiviral therapy for more than half a century with around 40 compounds approved by the FDA. Viral infections still represent a large public health problem due to the emergence of new viruses, the appearance of resistance to current antivirals and phenomena of viral mutations. This is why the design and synthesis of new antivirals are still relevant today. In the first part of this manuscript, in order to develop new, more active and safe antivirals, we firstly designed and synthesized two new families of olefinic acyclonucleosides phosphonates under prodrug form by modifying the nucleobase, the acyclic chain and the biolabile group. To do this, we used the cross-metathesis reaction as the key step. In the second part, the "scope" of Migita-Kosugi-Stille cross couplings was explored using stannylated iminoalditols and a small library of variously substituted aroyl chloride. More interestingly, the process of formation of the C‒C bond is stereoretentive. New analogs of C‒glycosylated N‒acetylglucosamine were then prepared by a reaction sequence of reduction, deprotection, mesylation and cyclization
Phelip, Capucine. "Conception, caractérisation et évaluation in vivo d'un vaccin nanoparticulaire anti-VIH et optimisation de sa biodisponibilité par un hydrogel thermosensible." Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1280.
Повний текст джерелаCurrent knowledge indicates the need to induce a broad-spectrum immune response including multifunctional antibodies to protect against HIV infection. As traditional vaccine approaches are not capable of inducing potent broad-spectrum neutralizing antibodies (bNAbs) against HIV-1, alternative strategies are being investigated to induce these bnAbs. Major advances include the development of (i) optimized envelope glycoproteins as immunogens, (ii) efficiently carrying and immunogenic carriers, and (iii) the dosage form that would increase the durability of the protective response. In this context, the objective of this PhD is to evaluate the immune responses induced by biodegradable nanoparticles functionalized with HIV envelope glycoproteins and to optimize the in vivo sustained release of the immunogen.First, we compared several glycoproteins and selected an optimized primary isolate glycoprotein (SOSIP BG505) for its ability to be adsorbed to the surface of biodegradable nanoparticles, while exposing neutralization epitopes, and capable of inducing a systemic immune response in vivo. We then designed a thermosensitive, poloxamers-based hydrogel, capable of incorporating these nanoparticles while maintaining their colloidal stability and we have analyzed their biodistribution by whole-body imaging in mice. The subcutaneous injection of this hydrogel makes it possible to induce a strong, stable humoral immune response with high affinity IgGs. This new formulation, innovative and easy to implement, appears as a new vaccination strategy applicable to many viral diseases requiring the induction of high affinity neutralizing antibodies and broad spectrum